LeadingBiotech: Boston BD is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Jonathan P. Gertler, M.D.
Managing Partner and CEO of Back Bay Life Science Advisors and Senior Director at BioVentures Investors

Profile

Jonathan P. Gertler, MD, is Managing Partner and CEO of Back Bay Life Science Advisors and Senior Director, BioVentures Investors. He has over 30 years of clinical and scientific experience, and extensive advisory work with biotechnology, diagnostic, medical device and health care IT companies in both the private and public sector. A former vascular surgeon and founder of several life science companies, Dr. Gertler is a frequent speaker and writer on strategic issues facing life science companies at all stages.

Before founding Back Bay in 2010, Dr. Gertler served as Senior Partner and Managing Director of Leerink Swann Strategic Advisors, Head of BioPharma Investment Banking at Leerink Swann & Company, as well as Head of Life Science Investment Banking at Adams Harkness/Canaccord Adams.

Dr. Gertler founded Antyllus Therapeutics, a development-stage biotechnology company focused on aortic diseases, and Biofeedback Systems Design, a healthcare IT company developed for the wellness market. Dr. Gertler also founded Cardiovascular Technologies, which successfully exited in 2001

Over the course of his advisory career, Dr. Gertler has counseled companies on growth and liquidity strategies and has been responsible for significant aggregate consideration in M&A, private and public equity for biotech, medtech, and HCIT companies. Prior to his advisory and consulting career and during the latter phases of his academic career, he was a Venture Partner at SV Life Sciences from 1997-2001.

Dr. Gertler was an academic vascular surgeon, primarily as Associate Professor of Surgery at Harvard Medical School and the Massachusetts General Hospital. He has published extensively in clinical vascular surgery and endothelial and smooth muscle cell biology and has served as an ad-hoc editor for the Journal of Vascular Surgery, The New England Journal of Medicine, The Journal of Critical Care Medicine and Surgery, among others. He currently serves on the Dean’s Advisory Board at Boston University School of Medicine and has previously been a board member of several private and public companies and non-profit organizations.

Dr. Gertler earned a medical degree from Columbia University College of Physicians and Surgeons, an MBA in Health Policy and Management from Boston University and a BA from Wesleyan University. He is a Fellow of the American College of Surgeons and a member of numerous academic and clinical surgical societies. Jonathan is a Series 24 Registered Securities Principal. He is married with three grown sons and is an avid musician, athlete and fly fisherman.

Jonathan P. Gertler, M.D.'s Network

Agenda Sessions

  • Designing Deals: Companies That Create Value Beyond Revenue

    ,